Passage Bio, Inc. (PASG)
4.75
+0.14
(+3.04%)
USD |
NASDAQ |
Sep 03, 13:40
Passage Bio Net Income (Annual) : -45.52M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -45.52M |
| December 31, 2024 | -64.77M |
| December 31, 2023 | -102.06M |
| December 31, 2022 | -136.12M |
| Date | Value |
|---|---|
| December 31, 2021 | -185.39M |
| December 31, 2020 | -112.23M |
| December 31, 2019 | -45.63M |
| December 31, 2018 | -12.77M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| ARS Pharmaceuticals, Inc. | -171.30M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |